TLDR:
- KIDRON Capital Assets has announced the first closing of a Women’s Health VC fund led by female General Partners.
- The fund targets untapped opportunities in Women’s Health across Europe, the USA, and Israel.
KIDRON Capital Assets has successfully closed the first round of funding for a venture capital fund dedicated to Women’s Health. The fund is led by two female General Partners with extensive experience in the HealthTech sector. Their primary goal is to capitalize on opportunities within the women’s health sector and generate superior returns for investors. The fund’s investment reach covers Europe, the USA, and Israel, and its diverse portfolio includes sectors such as medical devices, diagnostics, digital health, therapeutics, and services. KIDRON has already made investments in innovative U.S.-based companies like Beyond Medicine, Portal, and Renal Guard. These companies are focused on longevity solutions, oncology care, and preventing Acute Kidney Injury respectively. KIDRON invites investors to partner with them in driving innovation and making a difference in the future of women’s health.
